4//SEC Filing
Gilman Sydney A. 4
Accession 0001235802-20-000055
CIK 0001401040other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:36 PM ET
Size
6.0 KB
Accession
0001235802-20-000055
Insider Transaction Report
Form 4
Gilman Sydney A.
VP, Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2020-06-01+17,500→ 17,500 totalExercise: $4.64Exp: 2030-05-31→ Common Shares (17,500 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests in twelve nearly equal quarterly installments commencing on September 1, 2020.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001793016
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:36 PM ET
- Size
- 6.0 KB